UNITED STATES DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION MEMORANDUM OF AGREEMENTMemorandum of Agreement • May 4th, 2023 • Bright Green Corp • Medicinal chemicals & botanical products
ADDENDUMBright Green Corp • May 4th, 2023 • Medicinal chemicals & botanical products
The Drug Enforcement Administration and Bright Green Corporation (herein referred to as “Parties”) agree, within the terms set forth within this Memorandum of Agreement (MOA) that Bright Green Corporation will maintain plants of known cannabinoid content, or “Mother Plants”, in a segregated area within the controlled premise. Viable portions of the Mother Plant will be utilized to produce new plants, or “Progenies”, which will be harvested at certain stages of the Progenies’ lifecycle. Parties agree that portions of these Progenies harvested may be schedule I controlled substances or may be non-controlled substances (i.e. meeting the statutory definition of hemp, see 7 U.S.C. § 1639o; 21 C.F.R. § 1308.11(d)(31)(ii)). While all harvested material that is classified as a schedule I controlled substance under the Controlled Substances Act will be subject to the terms of this MOA, non-controlled substances derived from these plants will not be subject to the terms of this MOA.
